Sometimes I do feel I'm right, of course but, in this case I was really not sure
These syndromes, specifically those induced by vessel occlusion and subsequently treated with BPC 157, include inferior caval vein syndrome (Vukojevic et al., 2018), Pringle maneuver ischemia, reperfusion (Kolovrat et al., 2020), BuddChiari syndrome (Gojkovic et al., 2020), superior sagittal sinus occlusion (Gojkovic et al., 2021a), and superior mesenteric artery and/or vein occlusion (Knezevic et al., 2021a
In adults with growth hormone receptor deficiency, eight weeks of rhIGF-1 therapy significantly increased whole-body protein synthesis, decreased protein oxidation and increased lean body mass while reducing fat mass, demonstrating enhanced muscle anabolism and nutrient utilization in humans
That's where MIC B12 injections come in
This laboratory data is exactly what fuels the online marketing machine labeling it as the ultimate "gut-lining healer." In experimental rodent models of colitis, BPC 157 has shown real success in reducing tissue inflammation
Lets be honest, this is crucial